Description
The healthcare industry has seen significant developments in healthcare antitrust over the past few years. Healthcare saw an unprecedented level of antitrust enforcement by both state and federal regulators. State regulators proposed new legislation that would impact the review of future healthcare transactions.
In July 2023, the DOJ and the FTC issued a draft of the new Merger Guidelines, which would replace the 2010 Horizontal Merger Guidelines and the 2020 Vertical Merger Guidelines. The new guidelines explain how the current DOJ and FTC review mergers and acquisitions and their compliance with federal antitrust laws.
Listen as our authoritative panel of healthcare attorneys examines recent developments impacting healthcare antitrust and the implications for healthcare providers and others in the healthcare industry. The panel will discuss the recent draft Merger Guidelines as well as state regulatory changes. The panel will also review recent DOJ and FTC litigation. The panel will offer best practices for ensuring antitrust compliance.
Presented By
Mr. Greer focuses his practice in the areas of antitrust law and managed care contracting. As part of his antitrust practice, he has extensive experience in counseling health systems, hospitals and physicians on the antitrust requirements of mergers, acquisitions, joint ventures and provider networks. In this capacity, Mr. Greer frequently obtains clearance from the FTC and DOJ under the premerger reporting requirements of the Hart-Scott-Rodino (HSR) Act and defends providers in government antitrust investigations. During these government investigations, he manages complex procedural requirements, including large-scale document productions and electronic discovery and negotiates competition issues with the federal antitrust enforcement agencies. In addition, Mr. Greer routinely counsels healthcare providers on day-to-day antitrust compliance issues related to provider networks, managed care contracting, dominant firms and exchanges of competitively sensitive information, including “all or nothing” contracting, anti-tiering, anti-steering, gag clauses and price transparency. He also serves as part of an antitrust compliance monitoring team in monitoring antitrust agency consent orders.
Mr. Steren leverages his more than 30 years of healthcare antitrust and litigation experience to help healthcare clients manage the risks of joint ventures and other business arrangements and to defend them against government investigations and enforcement actions. He also provides counseling and litigation services to employers in connection with non-competition and pricing-related issues. Among Mr. Steren’s clients are large healthcare providers (or provider groups), such as hospitals and healthcare systems, physicians, ambulatory surgery center corporations, and other specialty care providers (e.g., chains of urological care or anesthesia providers). His clients also include large retail chains, commercial and residential lenders, and product manufacturers and distributors. A thought leader in the antitrust field, Mr. Steren speaks regularly and has authored numerous articles on antitrust issues affecting the healthcare industry.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Date + Time
- event
Tuesday, October 10, 2023
- schedule
1:00 p.m. ET./10:00 a.m. PT
- Federal guidance on mergers
- State regulatory changes
- DOJ and FTC litigation
- Implications of recent developments
- For healthcare antitrust
- For healthcare providers and other entities
- Best practices
The panel will review these and other key issues:
- New draft Merger Guidelines issued by the DOJ and FTC
- Changes to healthcare antitrust enforcement at the state level
- Healthcare antitrust under the Biden administration
